Assessment of the cost-effectiveness and clinical outcomes of a fourth generation synchronous telehealth program for the management of chronic cardiovascular disease: A longitudinal study

2016 ◽  
Vol 120 ◽  
pp. S32
Author(s):  
Yi-Lwun Ho
Keyword(s):  
Cardiovascular Disease ◽  
Longitudinal Study ◽  
Cost Effectiveness ◽  
Clinical Outcomes ◽  
Fourth Generation ◽  
The Cost

scholarly journals The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease

2021 ◽  
Author(s):  
Lars Holger Ehlers ◽  
Mark Lamotte ◽  
Sofia Monteiro ◽  
Susanne Sandgaard ◽  
Pia Holmgaard ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
The Cost

scholarly journals Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease

2014 ◽  
Vol 32 (7) ◽  
pp. 627-637 ◽  
Author(s):  
Laura T. Burgers ◽  
William K. Redekop ◽  
Johan L. Severens
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
The Cost

scholarly journals Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease

2013 ◽  
Vol 16 (7) ◽  
pp. A327
Author(s):  
L.T. Burgers ◽  
W.K. Redekop ◽  
J.L. Severens
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
The Cost

Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population

2016 ◽  
Vol 203 ◽  
pp. 422-431 ◽  
Author(s):  
Bob J.H. van Kempen ◽  
Bart S. Ferket ◽  
Ewout W. Steyerberg ◽  
Wendy Max ◽  
M.G. Myriam Hunink ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Cost Effectiveness ◽  
Risk Markers ◽  
The Us ◽  
Asymptomatic Individuals ◽  
The Cost
Sign in / Sign up

Export Citation Format

Share Document